The Role of SGLT2 Inhibitors in Heart Failure: A Systematic Review and Meta-Analysis.
Vasiliki TsampasianRanu BaralRahul Kumar ChattopadhyayMaciej DebskiShruti S JoshiJohannes ReinholdMarc Richard DweckAndrew J SwiftVassilios S VassiliouPublished in: Cardiology research and practice (2021)
The results of this meta-analysis confirm the growing evidence in the literature of the favourable profile of SGLT2 inhibitors in cardiovascular outcomes and mortality in patients with heart failure regardless of the baseline diabetes status. This systematic review has been registered with PROSPERO (CRD42021224777).